Home › Funds › THOMPSON SIEGEL & WALMSLEY LLC › BAX

THOMPSON SIEGEL & WALMSLEY LLC position in BAX

BAXTER INTL INC · Health Care

THOMPSON SIEGEL & WALMSLEY LLC reported holding 1,780,701 shares of BAX (BAXTER INTL INC) in its Q3 2026 13F filing — a position valued at US$42.7M, representing 0.80% of its reported portfolio and ranking #38 among its reported holdings. THOMPSON SIEGEL & WALMSLEY LLC has disclosed BAX holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.78M sh
Reported value held$42.74M
Portfolio Weight0.80%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How THOMPSON SIEGEL & WALMSLEY LLC's BAX position evolved

THOMPSON SIEGEL & WALMSLEY LLC first disclosed a stake in BAX in Q3 2023 at 4,109 shares (US$155K). The position peaked in Q1 2025 at 2,222,279 shares, worth US$76.1M. Across 12 filings, THOMPSON SIEGEL & WALMSLEY LLC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,780,701 shares valued at US$42.7M — a reduction of -837,717 shares quarter over quarter.. Notable position changes include a 35% increase in Q4 2024 (shares rose 18% over the following quarter), a 33% increase in Q3 2025 (shares fell 16% over the following quarter), a 32% trim in Q3 2026 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.11K $155.00K New
Q4 2023 4.11K $159.00K Hold
Q2 2024 2.01M $67.26M New
Q3 2024 1.89M $71.62M Reduce
Q4 2024 2.55M $74.31M Add
Q1 2025 2.22M $76.07M Reduce
Q2 2025 2.23M $67.46M Hold
Q3 2025 2.97M $67.66M Add
Q4 2025 3.33M $63.60M Add
Q1 2026 3.00M $50.36M Reduce
Q2 2026 2.62M $55.83M Reduce
Q3 2026 1.78M $42.74M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BAX and 13F data

BAX (BAXTER INTL INC) is a Health Care company. 14 other funds we track also report a position in BAX — the largest reported positions include Pzena Investment Management (US$1.50B), GREENHAVEN ASSOCIATES INC (US$297.5M), First Pacific Advisors, LP (US$185.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BAX

All BAX fund holders →

FAQ

How long has THOMPSON SIEGEL & WALMSLEY LLC held BAX?

THOMPSON SIEGEL & WALMSLEY LLC has disclosed BAX holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is THOMPSON SIEGEL & WALMSLEY LLC's current position in BAX?

As of Q3 2026, THOMPSON SIEGEL & WALMSLEY LLC holds 1.78M shares of BAX (BAXTER INTL INC), valued at $42.74M, representing 0.80% of its reported portfolio and ranking #38.

Has THOMPSON SIEGEL & WALMSLEY LLC been buying or selling BAX?

In the latest 13F filing (Q3 2026), THOMPSON SIEGEL & WALMSLEY LLC reduced its position in BAX. The position peaked in Q1 2025 at 2.22M shares.

Which other funds hold BAX?

Other major institutional holders of BAX include Pzena Investment Management, GREENHAVEN ASSOCIATES INC, First Pacific Advisors, LP, among 14 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.